Cosciens Biopharma Inc.
13F holders, Q4 2024 (December 31)15holders +6
6new positions
1sold out
$2.71avg. 13F price*
At the end of Q4 2024, 15 institutions reported holding Cosciens Biopharma Inc. in their 13F filings, up 6 from Q3 2024. 6 opened new positions and 1 sold out. The largest holders were National Bank of Canada ($16K), Royal Bank of Canada ($11K) and Federation des caisses Desjardins du Quebec ($10K).
- Company
- Cosciens Biopharma Inc.
- CUSIP
- 22112H101
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $9K |
| Exits | 1 | $7 |
All 13F filers, Q3 2024 → Q4 2024: 4,809 shares bought and 665 shares sold, net +4,144 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| National Bank of Canada | 0.00% | Add +2.1% | 5,920 | $16K |
| Royal Bank of Canada | 0.00% | Add +55.8% | 3,936 | $11K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -14.6% | 3,873 | $10K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 3,717 | $10K |
| MAI Capital Management | 0.00% | New | 1,151 | $3K |
| Citigroup Inc. | 0.00% | New | 902 | $2K |
| UBS Group AG | 0.00% | New | 686 | $2K |
| Morgan Stanley | 0.00% | New | 400 | $1K |
| SBI Securities Co., Ltd. | 0.00% | — | 165 | $457 |
| BNP Paribas Financial Markets | 0.00% | New | 100 | $271 |
| Osaic Holdings, Inc. | 0.00% | No change | 50 | $134 |
| Tower Research Capital LLC (TRC) | 0.00% | No change | 38 | $105 |
| Group One Trading LLC | 0.00% | New | 37 | $100 |
| Truvestments Capital LLC | 0.00% | No change | 22 | $61 |
| Groupe la Francaise | 0.00% | — | 1 | $8 |
"% of holder's portfolio" is COSCIENS BIOPHARMA INC's weight in each manager's 13F, not the share of Cosciens Biopharma Inc. the manager owns.